0001104659-21-075905.txt : 20210602 0001104659-21-075905.hdr.sgml : 20210602 20210602191604 ACCESSION NUMBER: 0001104659-21-075905 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210602 FILED AS OF DATE: 20210602 DATE AS OF CHANGE: 20210602 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BATE KENNETH CENTRAL INDEX KEY: 0001210238 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37467 FILM NUMBER: 21990793 MAIL ADDRESS: STREET 1: C/O MILLENNIUM PHARMACEUTICALS INC STREET 2: 40 LANDSDOWNE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CATABASIS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001454789 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 HIGH STREET STREET 2: 28TH FLOOR CITY: BOSTON STATE: MA ZIP: 02110 BUSINESS PHONE: 617-349-1971 MAIL ADDRESS: STREET 1: 100 HIGH STREET STREET 2: 28TH FLOOR CITY: BOSTON STATE: MA ZIP: 02110 4 1 tm2118270-6_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2021-06-02 0 0001454789 CATABASIS PHARMACEUTICALS INC CATB 0001210238 BATE KENNETH C/O CATABASISPHARMACEUTICALS, INC., 100 HIGHSTREET, FLOOR 28 BOSTON, MA 02110 1 0 0 0 Stock Option (right to buy) 2.04 2021-06-02 4 A 0 100000 0 A 2031-06-01 Common Stock 100000 100000 D This option was granted on June 2, 2021 and is schedule to vest in equal annual installments over a three-year period from the date of grant, subject to the director's continued service. /s/ Ben Harshbarger, as attorney-in-fact for Kenneth Bate 2021-06-02